roadmap gps 360€¦ · roadmap technologies planning and forecasting solutions •focus industries...

ROADMAP GPS 360BECAUSE PATIENT INTELLIGENCE IS BUSINESS INTELLIGENCE

ROADMAP TECHNOLOGIESPLANNING AND FORECASTING SOLUTIONS

• Focus Industries

• Life Sciences

• Consumer Electronics

• Geneva Technology

• Predictive Analytics/Expert System for Forecasting

• Analytic Platform for RoadMap Solutions

• Licensed to Oracle, Samsung, CPFR Vendors

• RoadMap GPS 360

• Global Planning Solution

• Business Intelligence and Visualization, Guided Analytics, Scenario Planning and Modeling

ROADMAP GPS 360

Source Systems

ERP – Patient Records - EMR

Advanced Models, Forecasting Algorithms, Statistical Analysis

Patient Demographics and Cohort Groups

Patient Analytic Processing and De-Identification

Patient Intelligence Database

BUSINESS INTELLIGENCE/VISUALIZATION

ROADMAP GPS 360 – BECAUSE PATIENT INTELLIGENCE IS BUSINESS INTELLIGENCE

• Top Down Business Intelligence is Not Enough…

• Product / Market / Time

• Units / Revenue / Pricing

• NRX / TRX

• Accurate Planning Requires Patient Intelligence…

• Patient Persistency

• Daily Consumption (DACON) by Patient Cohort

• Market Segment by Disease State/Indication

LIFE SCIENCES – ANALYTIC OPPORTUNITY

• Specialty Drug RX and Revenue Forecasting

• Long and expensive development cycles

• Shorter product life cycles

• High long-term value to patient and provider when patient stays on treatment

• Patient-level modeling of initial prescription (“trials”)

• Patient-level modeling of ongoing treatment (“repeat”)

• Critical to model patient cohorts along the life-cycle

• Improved forecast accuracy returns millions profits for a typical brand

• Improved service levels and inventory positions, fewer out-of-stocks, improved

pricing and promotions

ROADMAP GPS 360 FOR LIFE SCIENCES

•Near perfect demand forecast accuracy (98-99%) for Specialty

Pharmaceuticals (e.g. Drugs for MS, RA, Oncology)

• Traditional approaches fall short

• Top-down forecasting models fail to capture patient-level demand and

usage profiles hindering accuracy

• Tools-based approaches (SAS, SPSS, R) must be augmented by expensive

analytical staff and/or consultancy

PATIENT ANALYTICS: DRILLING DOWN TO THE MOST IMPORTANT PATIENT CHARACTERISTICS AND BEHAVIORS

• Demographics

• Phenotype (Physical Characteristics)

•Genotype (Genetic Variations)

• Indication (Disease State)

• Patient Persistency

• DACON

PATIENT-BASED ANALYTICS

360 DEGREES OF BUSINESS INTELLIGENCE

Top Line

Sales

Analytics

Cohort

Analysis

DemosStatistics

Forecasts

PATIENT COHORT – GROUP OF PATIENTS WHO STARTED THERAPY IN THE SAME YEAR

0

200

400

600

800

1000

1200

1400

1600

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

New Patients to Therapy

PATIENT ANALYTICS

Patient Cohorts

Planning Scenarios

Patient Data Measures

ROADMAP GPS 360 - PATIENT COHORT ANALYSIS

SEAMLESS SWITCHING BETWEEN SALES AND PATIENT ANALYTICS

360 DEGREES OF BUSINESS INTELLIGENCE

Top Line

Sales

Analytics

Cohort

Analysis

DemosStatistics

Forecasts

DEMOGRAPHICS: PATIENT AGE

Patient AgeAge Distribution by Patient

Cohorts

PHENOTYPE: BODY MASS INDEX (BMI)

Patient BMI

Patient BMI

GENOTYPE: GENETIC MARKERS

Genetic Markers

360 DEGREES OF BUSINESS INTELLIGENCE

Top Line

Sales

Analytics

Cohort

Analysis

DemosStatistics

Forecasts

INCIDENCE: DISEASE STATE

Disease States

PATIENT PERSISTENCY OF THERAPY OVER TIME

Patient Persistency

360 DEGREES OF BUSINESS INTELLIGENCE

Top Line

Sales

Analytics

Cohort

Analysis

DemosStatistics

Forecasts

PATIENT PERSISTENCY: KEY TO FORECAST ACCURACY

• Accurate Forecasts of Patient Persistency Drive Refill RX Forecasts

• Refills Forecasts are Typically within 1-2% Accuracy

• Refills RX can be 90-95% of Total RX Prescriptions for a Chronic Condition

ROADMAP 360 KEY BENEFIT PROPOSITION

• Patient-level Intelligence and Insight Improves Understanding of Patient

Persistency and Adherence to Therapy

• Advanced 360 Analytics and Modeling Leads to Faster and Smarter

Organizational Decision Making

• Significant Bottom-line Impact through Measurable Improvements in Forecast

Precision